← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-14 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 38개
AntibodySHOTFDACuratedFDABiologicAbbVieApproved

adalimumab (Humira, Hyrimoz, Amjevita)

Rheumatoid arthritis, psoriasis, Crohn's disease, ulcerative colitis, axial SpA · TNF-α

#TNF-#Antibody#Approved#FDA승인#바이오모아추천+5
효능 ORR 98.85%임상시험 532상태 APPROVED
ADCAHotBiologicGenentech, Inc.Approved

Methylprednisolone (Methylprednisolone)

Rheumatoid Arthritis · Ann Arbor Stage IIB Hodgkin Lymphoma

#AnnArborStageIIBHodgkinLymphoma#ADC#Approved#인기#항체약물접합체+3
효능 ORR 88%임상시험 147상태 RECRUITING
AntibodyCNovartis PharmaceuticalsApproved

Abatacept (Abatacept)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#인기#항체+4
효능 ORR 6.35%임상시험 72상태 ACTIVE
AntibodyBRocheApproved

Mabthera (Mabthera)

Rheumatoid Arthritis · FRα

#FR#Antibody#Approved#인기#항체+5
효능 ORR 84.7%임상시험 69상태 ACTIVE
AntibodyJanssenderuxtecan in ovarian cance…Phase 3

infliximab (Remicade, Remicade (infliximab))

Uveitis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#인기#항체+5
임상시험 62상태 ACTIVE
AntibodyMario Negri Institute for Pharm…Approved

Certolizumab pegol (Certolizumab pegol)

Rheumatoid Arthritis · Crohn's Disease

#CrohnsDisease#Antibody#Approved#인기#항체+4
효능 ORR 5%임상시험 60상태 ACTIVE
ADCBiologicPfizerPreclinical

pneumococcal conjugate vaccine (pneumococcal conjugate vaccine)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#ADC#Preclinical#인기#항체약물접합체+2
효능 ORR 89.87%임상시험 60상태 ACTIVE
ADCBiologicGlaxoSmithKlinePreclinical

pneumococcal polysaccharide vaccine (pneumococcal polysaccharide vaccine)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#ADC#Preclinical#인기#항체약물접합체+2
효능 ORR 89.87%임상시험 60상태 ACTIVE
AntibodyGenentech, Inc.Phase 2

Ocrelizumab (Ocrelizumab)

Rheumatoid Arthritis · Multiple Sclerosis

#MultipleSclerosis#Antibody#Phase2#인기#항체+5
임상시험 58상태 DISCONTINUED
AntibodystaleGilead SciencesPhase 1

Andecaliximab (Andecaliximab)

Gastric Adenocarcinoma · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase1#항체#면역항체+3
효능 ORR 9.7%임상시험 3상태 DISCONTINUED
AntibodystaleUCB PharmaApproved

CZP (Certolizumab Pegol, Certolizumab Pegol (CZP))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 3상태 ACTIVE
AntibodystaleRochePhase 2

rituximab (MabThera®, MabThera® (rituximab))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#항체#면역항체+2
임상시험 3상태 DISCONTINUED
AntibodystaleNovartis PharmaceuticalsPhase 2

Secukinmab (Secukinmab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#항체#면역항체+2
임상시험 3상태 ACTIVE
AntibodystaleRochePhase 2

rituximab (Rituxan, Rituxan (rituximab))

Rheumatoid Arthritis · Lupus Erythematosus, Systemic

#LupusErythematosusSystemic#Antibody#Phase2#항체#면역항체+3
임상시험 2상태 ACTIVE
AntibodystaleBristol-Myers SquibbPhase 3

Abatacept (ABA, Abatacept, Abatacept (ABA) + Methotrexate (MTX), double-blind (DB))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleHanyang UniversityPreclinical

Adalimuab, Etanercept, Tocilizumab, or Abatacept (Adalimuab, Etanercept, Tocilizumab, or Abatacept)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleMerck KGaA, Darmstadt, GermanyPhase 2

Atacicept (Atacicept)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity of CagliariPreclinical

Belimumab in SLE patients / Rituximab in RA patients (Belimumab in SLE patients / Rituximab in RA patients)

Systemic Lupus Erythematosus; Rheumatoid Arthritis · Systemic Lupus Erythematosus

#SystemicLupusErythematosus#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleShanghai Biomabs Pharmaceutical…Phase 3

CMAB008 (CMAB008)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity of Illinois at Chica…Approved

CDP870, tradename Cimzia (Certolizumab pegol, Certolizumab pegol (CDP870, tradename Cimzia))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE

1 / 2 페이지

← 이전다음 →